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HIGHLIGHTS 
 Only 12 studies was found of which 10 studies focused on cytokines, 1 study focused on adipokines, and 1 study 
included both cytokines and adipokines.  
 There is no strong evidence that confirms a positive or negative effect of exercise on cytokine or adipokine in MS 
patients, yet this research in plagued by methodological weaknesses. 
 In relation to cytokines or adipokines, no studies reported harmful effects of exercise 
 Regular physical activity did not lead to an increase in pro-inflammatory cytokines or adipokines as well as disease 
severity.  
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Abstract 
Background: Physical activity, particularly exercise training, is an evidence-based approach for managing symptoms, 
restoring function and improving overall wellness in people with multiple sclerosis (MS). Several recent studies have 
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argued for a potential disease modifying effect of exercise in people with MS, and among the potential mediating 
mechanisms are exercise training effects on both cytokines and adipokines.  The objectives of this study were to perform a 
systematic review of exercise training effects on cytokine and adipokine profiles in persons with MS.  
Methods: We conducted open-dated searches of PubMed, Cochrane Library, EMBASE and PEDro using the terms 
‘Multiple sclerosis’ or ‘MS’ AND ‘exercise’ OR ‘training’ OR ‘physical activity’ AND ‘cytokine’ OR ‘inflammatory’ OR 
‘immune’ OR ‘adipokine’. Included studies were written in English; comprised of humans with MS, and evaluated the 
effects of regular physical activity or exercise on pro-inflammatory, anti-inflammatory cytokines or adipokines. Two 
authors independently scanned titles and abstracts, and read the studies included. All studies were rated on the PEDro scale 
and further classified based on American Academy of Neurology criteria.  
Results: Twelve studies were included of which 10 studies focused on cytokines, 1 study focused on adipokines, and 1 
study included both cytokines and adipokines. The selected studies included 3 Class I studies, 7 Class II studies, and 2 Class 
IV studies and had average PEDro scores of 6.9±1.6. Studies included endurance (n=5), resistance (n=3), combined (n=3), 
and vibration (n=1) training. Overall, there is a general lack of standardization of procedures across studies and inconsistent 
evidence for the effects of physical activity and exercise on cytokine and adipokine profiles in MS, with a general pattern 
indicating a lack of effect.  
Conclusion: Research regarding the effects of exercise training on cytokines and adipokines in MS is in its infancy, but 
exercise represents an adjuvant therapy in MS, and future studies are essential for clarifying the role of exercise on 
cytokines and adipokines in MS. 
Key words: Exercise; Multiple sclerosis; Cytokine; Adipokine; Demyelination 
 
 
 
 
Abbreviations 
MS = Multiple sclerosis 
Th = T helper 
IL = Interleukin 
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TNF-α = Tumor Necrosis Factor alpha 
CNS: Central Nervous System 
MeSH: Medical Subject Headings 
RCT = Randomized control Trial 
PEDro = Physiotherapy Evidence Database 
AAN = American Academy of Neurology 
RRMS = Relapsing-Remitting Multiple Sclerosis 
IFN-γ = Interferon gamma 
Vo2max = maximum Rate of Oxygen 
Vo2peak = Peak rate of Oxygen 
1RM = One-repetition Maximum 
EDSS = Expanded Disability Status Scale 
MVC = Maximum Voluntary Contraction 
BDNF = Brain-Derived Neurotrophic Factor 
NGF = Nerve Growth Factor 
CRP = C-Reaction Protein 
TGF-β = Transforming growth factor beta. 
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1. Introduction 
 
There is increasing emphasis on the importance of regular physical activity, particularly exercise training, among people with multiple sclerosis (MS). The evidence 
base has resulted in recommendations that exercise training can be incorporated in the comprehensive care of persons with MS for managing many health and wellness 
aspects of this disease (Herring et al., 2017; Latimer-Cheung et al., 2013; Motl and Pilutti, 2012; Platta et al., 2016). There is further speculation that exercise training 
may have disease modifying effects for persons with MS (Motl and Pilutti, 2012; Zimmer et al., 2017), and this is largely based on initial evidence for exercise training 
effects on relapses, brain atrophy and disability progression. Researchers recently suggested a renewed focus regarding the effects of exercise training on cytokines and 
adipokines based, in part, on the potential for MS disease modification (Alvarenga-Filho et al., 2016; Bansi et al., 2013; Briken et al., 2016; Kjølhede et al., 2016; 
Mokhtarzade et al., 2017). This renewed focus is further based on evidence for exercise training effects on markers of immune system function in the general 
populations of adults (Gjevestad et al., 2015; Gondim et al., 2015).  
Cytokines are an essential part of the pathophysiology of MS (Patel and White, 2013). Cytokines are proteins secreted from different tissues and influence the 
reproduction, differentiation, proliferation and function of immune cells (Alexander, 2002). There is a balance between T helper cytokines in healthy persons, whereas in 
MS this balance shifts and reflects increased Th1 pro-inflammatory cytokines resulting in increases in cytokines such as interleukin (IL)-1, IL-6 and tumor necrosis 
factor (TNF-α). On the other hand, secretion of Th2 anti-inflammatory cytokines, such as IL-10, is decreased in MS and this can intensify the destruction of myelin and 
prevent remyelination (Turner et al., 2009). The higher concentration of most pro-inflammatory cytokines is associated with CNS inflammation that is observed in MS 
pathogenesis and can intensify demyelination processes in the CNS (Lovett-Racke et al., 2004; Patel and White, 2013). Consequently, regulation of the balance between 
Th1 and Th2 cytokines, and the reduction of inflammation, is accompanied with the control and improvement of MS pathogenic processes involving axonal 
demyelination and transection (Cannella and Raine, 2004; Lovett-Racke et al., 2004; Sospedra and Martin, 2005; Turner et al., 2009). 
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The induction of inflammation by the immune system is linked with many factors. One of these factors is adipose tissue and associated cytokine production by 
adipokines (Ebrahimi et al., 2015; Mokhtarzade et al., 2017), and there is strong evidence that adipokines are involved in the immune pathophysiology of MS (Kraszula 
et al., 2012; Procaccini et al., 2017; Rotondi et al., 2013). For instance, leptin (as one adipokine) is involved in neurodegenerative and inflammatory processes associated 
with MS (Rotondi et al., 2013). Previously, studies have verified the role of adipokines on body energy balance and regulation of food intake and body weight, and the 
important role of leptin in the immunological function via regulation of Th1/Th2 balance are well known (Farrokhi et al., 2016). Cytokines and adipokines closely 
interact with each other in the immune pathophysiology of MS, and this underscores the importance of monitoring both cytokines and adipokines especially in the 
immune system of MS. 
Disease modifying drugs represent the first line of treatment for MS. These drugs, however, do not provide complete control over the cytokine or adipokine profiles 
in MS (Mokhtarzade et al., 2017; Motl et al., 2017). This is important as it highlights the important consideration of other approaches for managing the balance of 
cytokines or adipokines in MS, including exercise training. Indeed, we are aware of three papers that have advocated exercise as a possible disease modifying therapy in 
MS (Dalgas and Stenager, 2012; Heesen et al., 2006; Majdinasab et al., 2018; Motl et al., 2015) and noted that this may occur through modification of the immune 
system in persons with MS.  
Several mechanisms may mediate the effect of exercise on cytokines, most of which involve the reduction in fat mass subsequently decreasing adipokine secretion 
and induction of an anti-inflammatory environment through releasing cytokines from contracting skeletal muscle and reduction expression of Toll-like receptors (TLR) 
on monocytes and macrophages (Gleeson et al., 2011). In general, the concept that exercise independently of weight loss or other interventions can affect cytokines and 
adipokines is well accepted. Furthermore, there is comprehensive evidence on the role of exercise and physical activity as an anti-inflammatory intervention for 
modulating cytokines in non-MS subjects (Gleeson et al., 2011; Smart and Steele, 2011). For instance, previous systematic review (Smart and Steele, 2011) that 
investigated acute and chronic effect of exercise on inflammatory markers such as cytokines in people with a chronic inflammatory disease reported that levels of 
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inflammatory markers, such as IL-6 acutely increased after exercise and remained elevated longer into the recovery period; Moreover, chronic endurance training can 
reduce systemic inflammation, especially pro-inflammatory cytokines, in people with type II diabetes and chronic heart failure. 
To date, there is no comprehensive systematic review regarding the effect of regular physical activity on cytokine and adipokine expression in MS. We 
systematically reviewed human randomized control trials (RCTs) and non-RCTs (i.e., clinical trials without a control condition) published before October 2017 that 
included persons with MS, and examined the effect of exercise training on cytokines and adipokines and provided guidance on future research in this largely neglected 
area of the biochemical mechanisms that may explain exercise effects in MS.  
 
2. Materials and methods 
 
This review is based on a systematic literature search of 4 electronic databases (PubMed, Cochrane Library, EMBASE, and PEDro) to identify studies that 
investigated the effect of regular physical activity on cytokines and adipokines in MS, published until October 2017. Physical activity was defined as bodily movement 
produced by muscle activity that requires more energy than resting, whereas exercise is a subset of physical activity that is planned, structured, and repetitive and has an 
objective of improving or maintaining physical fitness (Caspersen et al., 1985) (See Box1).  
The Medical Subject Heading (MeSH) terms guiding the search included (‘Multiple sclerosis’ or ‘MS’) AND (‘exercise’ OR ‘training’ OR ‘physical activity’) 
AND (‘cytokine’ OR ‘inflammatory’ OR ‘immune’ OR ‘Adipokine’). This search strategy identified 142 published articles (Figure 1). Two reviewers independently 
screened each article based on titles, keywords and abstracts to ensure all articles were captured. Inclusion criteria were: English language, access to full texts, studying 
the effects of regular physical activity in MS patients (RCT or other clinical trial), studying pro-inflammatory and anti-inflammatory cytokines or adipokines. If a study 
used other interventions such as medicines or supplements in addition to physical activity, we excluded them from this review. After the omission of duplicate studies, 
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12 studies were included in the review. Studies included and excluded were reviewed separately by two researchers. The reviewed papers were then examined based on 
methodological quality and classified based on individual levels of evidence. 
 
2.1. Methodological quality 
Methodological quality of studies was evaluated using the original 11-item Physiotherapy Evidence Database (PEDro) scale, which is described in detail 
elsewhere (Maher et al., 2003). The PEDro scale (Pilutti et al., 2014; Sá, 2014) characterizes the methodological quality of a study based on 11 criteria and yields a score 
between 0 to 10 (criteria 1 does not add to the score), whereby higher scores indicate superior methodological quality. Scores between 0-4 reflect low methodological 
quality, scores between 5 or 6 reflect fair methodological quality, and scores between 7-10 reflect high methodological quality (Foley et al., 2003) (for more information 
https://www.pedro.org.au/wp-content/uploads/PEDro_scale.pdf). 
 
2.2. Classification and recommendations  
Classification of studies was carried out according to the criteria provided by the American Academy of neurology (ANN). ANN classification is a standard 
published index for therapeutic studies that divides studies into four levels of evidence (supplement data table 1). After classification of reviewed studies, overall 
recommendations (based on ANN guidelines) were provided based on physical activity/exercise having a positive, neutral, or harmful effect on cytokines and adipokines 
within the four recommend Classes (see supplement data table 2) (Sandroff et al., 2016). 
 
3. Results 
 
3.1. Study characteristics 
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We located 907 studies, and 12 articles were eligible to be included in this review after examining inclusion and exclusion criteria. Ten studies focused on the 
effect of exercise training on cytokines, one study focused on the effect of exercise training on adipokines, and one study included both cytokines and adipokines as 
outcome measures (Mokhtarzade et al., 2017). The characteristics of the 12 studies regarding clinical characteristics and exercise protocol are reported in Table 2. There 
were 412 participants included in the reviewed studies; 22 of them were healthy controls and 366 of them were individuals with MS. Regarding gender, 261 (71%) 
participants were women, and the remainder were male (n=105, 29%). Two studies included only women (Golzari et al., 2010; Mokhtarzade et al., 2017), whereas both 
genders were included in 10 studies (83%) (Alvarenga-Filho et al., 2016; Briken et al., 2016; Castellano et al., 2008; Deckx et al., 2016; Ebrahimi et al., 2015; 
Kierkegaard et al., 2016; Kjølhede et al., 2016; Schulz et al., 2004; White et al., 2006). Among the 46 subjects who dropped-out of the studies, 32 cases were in the 
exercise training groups (14%) and 14 cases were in the control groups (9%). There were 2 (1%) and 5 (3%) cases excluded from both the training and control groups, 
respectively, based on the occurrence of a relapse. Participant age was between 18 and 60 years. Seven studies focused on RRMS type of MS (Alvarenga-Filho et al., 
2016; Bansi et al., 2013; Ebrahimi et al., 2015; Kierkegaard et al., 2016; Kjølhede et al., 2016; Mokhtarzade et al., 2017; White et al., 2006), whereas 2 studies included 
two types of MS (Deckx et al., 2016; Mokhtarzade et al., 2017) or did not report the type of MS (3 studies: 25%). MS diagnosis in 4 studies (Bansi et al., 2013; Deckx et 
al., 2016; Ebrahimi et al., 2015; Kjølhede et al., 2016) was based on McDonald  (McDonald et al., 2001) or revised McDonald (Polman et al., 2011) criteria; 2 studies 
(Castellano et al., 2008; Schulz et al., 2004) used Poser (Poser et al., 1983) criteria, whereas the other studies did not specify diagnostic criteria or use any other criteria 
for MS diagnosis. EDSS scores of MS subjects in these studies were between 0 and 6.5. All studies except Kierkegaard et al., 2016 and White et al., 2006 had two group 
comparisons (training vs. control group). Bansi et al., 2013 compared land versus water-based exercise. Alvarenga-Filho et al., 2016 was the only study to use a healthy 
matched control group as well as trained and untrained MS groups (see studies description in supplement materials)  
The reviewed studies used aerobic or endurance (5 studies), resistance (3 studies), combined (3 studies) and vibration (1 study) training (see table 2), but no 
studies had the same exercise training protocol. The frequency of exercise sessions was 2 or 3 sessions per week in the studies. Most studies did not report any 
progression in the session’s frequency during the training period. Intensity of exercise was moderate and high in most studies, and was designed based on heart rate, 
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maximum watts and maximal aerobic capacity. Exercise intensity was considered constant, and the applied progression of exercise intensity was not reported. The 
duration of the training protocol ranged between 3 (Bansi et al., 2013) and 24 (Kjølhede et al., 2016) weeks. 
 IL-6 and TNF-α were the most commonly assayed cytokines with IL-6 reported in 8 studies (Alvarenga-Filho et al., 2016; Bansi et al., 2013; Briken et al., 
2016; Castellano et al., 2008; Deckx et al., 2016; Kierkegaard et al., 2016; Schulz et al., 2004; White et al., 2006) and TNF-α in 7 studies (Alvarenga-Filho et al., 2016; 
Bansi et al., 2013; Castellano et al., 2008; Deckx et al., 2016; Kjølhede et al., 2016; Mokhtarzade et al., 2017; White et al., 2006). IL-10 (Alvarenga-Filho et al., 2016; 
Deckx et al., 2016; Kjølhede et al., 2016; Mokhtarzade et al., 2017; White et al., 2006) and IFN-γ (Alvarenga-Filho et al., 2016; Castellano et al., 2008; Golzari et al., 
2010; Kjølhede et al., 2016; White et al., 2006) were both included in 5 studies. Leptin was the most commonly reported adipokine in the reviewed studies (2 studies, see 
table 3). 
 
3.2. Methodological quality and study classification  
The PEDro scale described the methodological quality of studies. PEDro scores ranged between 3 and 8, and the mean PEDro scale score was 5.9 ± 1.5, 
reflecting fair methodological quality (table 1). Five studies (Briken et al., 2016; Deckx et al., 2016; Kjølhede et al., 2016; Mokhtarzade et al., 2017; Schulz et al., 2004) 
were of high quality (score 7 and above). Of the 12 studies included in the current review, 3 provided Class I evidence, 7 Class II evidence, and 2 Class IV evidence; 
there were no studies providing Class III evidence.  
 
3.3. Classification of Evidence 
 
3.3.1. Cytokines 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
11 
 
 
Evidence from 7 of 8 studies (i.e., 1 Class I study and 6 Class II studies,) does not support the efficacy of exercise training for changing IL-6 concentration due 
to non-significant results (Alvarenga-Filho et al., 2016; Bansi et al., 2013; Briken et al., 2016; Castellano et al., 2008; Deckx et al., 2016; Schulz et al., 2004; White et 
al., 2006), however one study (Kierkegaard et al., 2016) did report a reduction. Therefore, current data on IL-6 resulted in classification B.  
Evidence from 4 of 7 studies focused on TNF-α included 1 Class I study (Kjølhede et al., 2016) and 3 Class II studies (Alvarenga-Filho et al., 2016; Bansi et al., 
2013; White et al., 2006), does not support the efficacy of regular exercise training. Evidence from 1 of 7 studies (Class II) does support the efficacy of exercise training 
for significantly increasing TNF-α levels (Castellano et al., 2008), while 2 studies including Class I (Mokhtarzade et al., 2017) and Class II (Deckx et al., 2016) report 
redaction of TNF-α level in an individual with MS. Therefore, current results classify as non-applicable, since data sets are inadequate and conflicting.  
The results of 4 of 5 studies (2 Class I and 2 Class II) do not support the efficacy of exercise training for improving IL-10 level based on non-statistically 
significant results (Alvarenga-Filho et al., 2016; Deckx et al., 2016; Kjølhede et al., 2016; Mokhtarzade et al., 2017). Moreover, 1 of 5 studies (Class IV) indicate 
efficacy of exercise training to decrease IL-10 level in MS subjects (White et al., 2006). Taken together, this resulted in classification A, since exercise training is 
ineffective in changing IL-10 levels in persons with MS.  
Evidence and results from other cytokine studies are not meaningful and do not support the efficacy of exercise training for improving the cytokine profile. 
Therefore, results from other cytokines are classified as non-applicable based on conflicting evidence, in the sense that data are inadequate or conflicted. 
 
3.3.2. Adipokines 
Only 2 studies investigated effect of exercise training on adipokines in people with MS. One of the 2 studies provided Class I evidence and indicated an effect 
of exercise training for improving leptin (Mokhtarzade et al., 2017), yet 1 Class II study (Ebrahimi et al., 2015) indicated that exercise training did not have an effect on 
leptin. Therefore, current evidence is described as non-applicable reflecting that the data are inadequate or conflicting. 
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4. Discussion 
 
There is a small corpus of research examining the effect of regular physical activity on the pathophysiology of MS with an emphasis on cytokines or 
adipokines. The present systematic review included 12 studies on the effects of exercise training on cytokine and adipokine profiles in persons with MS. This included 3 
Class I studies, 7 Class II studies, and 2 Class IV studies on cytokines, and only 1 Class I study and 1 Class II study on adipokines. Overall, most studies do not support a 
substantial impact of exercise training on cytokines and adipokines in persons with MS, but methodological flaws of the studies may bias a clear interpretation. 
However, no harmful effects of exercise modalities were noted for cytokines or adipokines, although this was not the intended purpose of the studies and the studies did 
not examine exercise effects during a relapse. 
 
4.1. Effect of exercise on Cytokines 
The cytokines that are of primary focus in MS studies include a diverse spectrum of pro-inflammatory cytokines such as IL-1, IL-2, IL-6, IL-17, IFN-γ and 
TNF-α, and anti-inflammatory cytokines such as IL-1ra, IL-4 and IL-10. The major source of most of these cytokines are immune system cells such as T cells, 
macrophages, B cells, monocytes and natural killer cells that can induce inflammatory or anti-inflammatory effects through different mechanisms (Kierkegaard et al., 
2016; Kjølhede et al., 2016).  
Though significant work has been done in the study of the cytokine changes with exercise in the general population (Gjevestad et al., 2015; Gondim et al., 
2015), the effect of exercise on cytokines remains inconclusive in MS subjects. For example, two Class IV studies (Kierkegaard et al., 2016; White et al., 2006) reported 
significant decreases in the level of IL-4 after training, whereas one Class I (plasma level) and one Class II (plasma level and production by peripheral blood 
mononuclear cell, PBMC) study (Golzari et al., 2010; Kjølhede et al., 2016) did not find any differences. This contradiction in results was observable in other cytokines, 
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and makes it difficult to surmise a definitive conclusion on the effects of regular physical activity in MS subjects; although there is no doubt about the usefulness of 
regular physical activity for MS patients particularly for improved fitness and corresponding quality of life (Herring et al., 2017; Sandroff et al., 2016). 
Among the reviewed studies, 5 studies investigated the effect of regular physical activity on IL-10. Four studies (two Class I and two Class II studies) reported 
no change for IL-10 level (Alvarenga-Filho et al., 2016; Deckx et al., 2016; Kjølhede et al., 2016; Mokhtarzade et al., 2017) and one Class IV study reported a 
significant reduction (White et al., 2006). IL-10, known as human cytokine synthesis inhibitory factor, is an anti-inflammatory cytokine associated with MS relapses. It 
should be noted that Alvarenga-Filho et al., 2016 and Deckx et al., 2016 elevated IL-10 secreation from T cells and regulatory type 1 cells, respectively, which was 
different with other studies that elevated IL-10 levels in serum and plasma. Evidence suggests that IL-10 secreted by Th2 cells down-regulates the production of pro-
inflammatory cytokines from Th1 cells (Mokhtarzade et al., 2017). Moreover, IL-10 is an important factor for monitoring the response to medication and disease 
progression. Specifically, treatment with IFN-β increases concentrations of IL-10 to protect against the pro-inflammatory cytokines such as IFN-γ and TNF-α 
(Mokhtarzade et al., 2017). Therefore, increase in the level of IL-10 could partly explain the beneficial effect of regular physical activity in MS subjects. However, most 
of the reviewed studies report no marked change on IL-10 anti-inflammatory factor.  
It seems that IL-10 is affected by multiple factors, such as adiposity, baseline fitness and exercise duration (Alvarenga-Filho et al., 2016; Briken et al., 2016; 
Mokhtarzade et al., 2017). So, short training periods (often less than 8 weeks) and the low level of the physical fitness of MS patients compared to healthy individuals 
are two major reasons for the inefficiency of regular physical activity on cytokines in the reviewed studies (Briken et al., 2016; Kjølhede et al., 2016; Mokhtarzade et al., 
2017). On the other hand, most of reviewed studies have not paid attention to the metabolic and/or body composition changes resulting from training that can affect the 
immune system and its adaptation to exercise. Interestingly, Mokhtarzade et al., 2017 demonstrated that IL-10 changes following interval aerobic exercise training is 
associated with improved aerobic capacity in MS subjects. Mokhtarzade et al., 2017 concluded that the low level of physical fitness in MS subjects is probably one of 
the reasons for the lack of significant improvement in IL-10 level after a training period. In addition, Weinhold et al., 2015 reported that increasing levels of IL-10, 
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which is produced from the regulatory T-cells, after exercise is associated with fitness level (Weinhold et al., 2016). It is worth noting that investigating the role of anti-
inflammatory cytokines in the context of MS regardless of pro-inflammatory cytokines such as IL-6 and TNF-α can be incomplete. 
One Class I, five Class II and two Class IV studies focused on the effect of regular physical activity on IL-6, from which one Class IV study reported a 
significant reduction (Kierkegaard et al., 2016) and other studies have reported no considerable change (Alvarenga-Filho et al., 2016; Bansi et al., 2013; Briken et al., 
2016; Castellano et al., 2008; Deckx et al., 2016; Schulz et al., 2004; White et al., 2006) after a training period. Similar to IL-10, IL-6 results are also contradictory; 
however most of the studies show that the serum level of IL-6 is not changed after the training. One common theme across studies is that the overall unconvincing 
evidence for IL-6 might be biased by studies that did not assess IL-6 in several tissues such as muscle and adipose, and also failure to report the pharmacological 
treatment effect on cytokine status. Interestingly, one Class II study (Alvarenga-Filho et al., 2016) indicated that serum levels of IL-6 is chronically higher in MS 
subjects and there is a significant relationship between IL-6 and fatigue. Despite this, in our laboratory and in an unpublished study, we observed that the level of IL-6 is 
higher in relapse and remitting MS subjects at rest. Furthermore, IL-6 exacerbates the demyelination process and inflammation (Sharief, 1998). Based on the importance 
of IL-6 in the CNS, reduction of this factor is of potential great clinical significance in MS patients (Sharief, 1998). Based on the stimulating effects on T cells and the 
data suggesting that IL-6 has the potential to aid in the progression of MS (Arnett et al., 2003; Molanori Shamsi, 2010), many studies have considered IL-6 as a pro-
inflammatory cytokine, but some studies emphasize the anti-inflammatory role of IL-6 (Alvarenga-Filho et al., 2016; White et al., 2006). IL-6 secretion from skeletal 
muscle during exercise stimulates hepatic glucose release into the circulation. The reduced resting concentrations of IL-6 after adaptation to exercise in healthy and 
obese subjects was associated with a reduction in glucose dependence (Agha Alinejad et al., 2010; Molanori Shamsi, 2010; Ozenci et al., 1999).  
Another important and interesting pro-inflammatory cytokine is TNF-α. Seven studies investigated the effect of exercise training on TNF-α, and these studies 
include one Class I, three Class II and one Class IV study have reported no significant change (Alvarenga-Filho et al., 2016; Bansi et al., 2013; Deckx et al., 2016; 
Kjølhede et al., 2016; White et al., 2006). Only one Class II (Golzari et al., 2010) and one Class I (Mokhtarzade et al., 2017) study showed significant increases and 
decreases in TNF-α levels, respectively. Overall, the evidence for the effects of exercise training on TNF- α was conflicting, and involved studies of relatively weak 
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methodological quality (i.e., only 1 Class I study). However, the contradictory results may result from a dual role of TNF-α. Although, it has been reported that an 
increase in TNF-α is associated with disturbance of the blood brain barrier and axonal demyelination (Elenkov and Chrousos, 2002; Minagar and Alexander, 2003), 
TNF-α is also associated with the reduction in the relapse events with IFN-b treatment (Sharief and Hentges, 1991; Simpson et al., 2015) and stimulation of 
remyelination by increasing the oligodendrocyte proliferation (Arnett et al., 2003).  
The dual role of TNF-α in MS disease is complex. Reports suggest that exercise training increases the p75 receptor protein concentrations promoting 
neuroprotection (Mokhtarzade et al., 2017). It should also be noted that in damaged cells and in cancer pathology, the pathway of both TNF-α receptors is associated 
with cell death and induction of inflammation (Arnett et al., 2001; Arnett et al., 2003; Elenkov and Chrousos, 2002); a plausible response in the cells of the CNS during 
MS relapses and progression. As stated, one of the human pro-inflammatory cytokine synthesis inhibitory factors is IL-10, but almost all studies suggest that exercise 
cannot improve IL-10 secretion. Therefore, the non-reduction in TNF-α response to training in previous studies, can be attributed to the lack of change in IL-10. 
 
4.2. Effect of exercise on adipokines 
Two studies evaluated the effect of regular physical activity on the peripheral blood circulation level of adipokines. In these studies, vibration and interval 
aerobic exercises were used as interventions, and the studies observed either no change or a decrease in the resting levels of leptin, as an inflammatory mediator. A Class 
II study (Ebrahimi et al., 2015) observed no change in leptin as an inflammatory mediator, Ghrelin or body mass index. The relationship between leptin and fat mass, 
and the lack of significant change in fat mass may help explain this result. This study had some methodological concerns from an exercise prescription standpoint. 
Indeed, it seems that vibration training was not intense enough; therefore, the maximal benefits of exercise training on leptin could not be realized. On the other hand, the 
Class I study (Mokhtarzade et al., 2017) reported a significant decrease in serum levels of leptin and a significant increase in adiponectin. The results also showed a 
significant improvement in the body composition profile of MS subjects.  
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Recent studies have focused on the role of adipose tissue and secreted adipocytokines from adipose tissue such as leptin (Devorak et al., 2017; Frisullo et al., 
2004; Kraszula et al., 2012; Meier and Gressner, 2004; Procaccini et al., 2017). Evidence has supported important and complex features of the interaction between 
nutrition, metabolism and the hemostasis of the immune system (Procaccini et al., 2017; Procaccini et al., 2015). Therefore, leptin is considered a pivotal factor to 
control weight by controlling nutrition and consumption of energy. It has also been suggested that leptin plays an important role in the regulation of several adaptive and 
innate immune functions (Procaccini et al., 2017). In other words, leptin plays a key role in connecting metabolic changes and the immune system. In fact, leptin 
stimulates T cell proliferation, monocyte and macrophage activity and production of inflammatory cytokines (IL-1, Il-12 and TNF-α) (Kraszula et al., 2012; Meier and 
Gressner, 2004; Procaccini et al., 2015). Frizullo et al., 2004 have demonstrated that leptin is related to the relapse of MS by stimulating the secretion of IL-6 and TNF-
α. Consequently, interpretation of leptin’s role based on cytokine changes can provide interesting conclusions. 
 
4.3. Future research 
There is a complex link between the immune system and adipose tissue. On the other hand, adipose tissue is associated with other risks, including 
cardiovascular risk and even mortality (Hedström et al., 2012; Lin et al., 2017; Munger et al., 2013). With leptin as an example, the three-way connection between 
nutrition, metabolism and the immune system needs to be examined. Recent research has reported that, in addition to leptin, other adipocytokines, such as adiponectin 
and resistin, may affect the immune system (Kraszula et al., 2012) and may have role in MS pathogenesis, requiring further research. One of the main causes of 
difference in the results reviewed in this paper are likely attributable to differences in exercise protocol type, duration and exercise intensity. Reviewed studies have 
often used only a single type of exercise as an intervention, and there is no comparison between different types of exercise and intensities. Therefore, it is suggested that 
comparisons between different exercises should be made to determine the most effective exercise modality in terms of the effect on cytokine profile. Furthermore, there 
are significant requirements for standardized high quality studies that investigate both short and long term effects of an active lifestyle on clinical and Para clinical 
parameters in patients with MS. Although most studies did not show chronic effects of exercise on cytokines, we know that acute effects may also be important. It may 
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be that the positive effects of exercise should rather be seen as the sum of acute effects, leading to long term improvements (Bansi et al., 2013; Kjølhede et al., 2016). It 
seems that acute exercise induces a short term inflammatory environment, this is followed by a mid-term anti-inflammatory environment; therefore, studies should 
particularly pay attention to the acute effects of exercise and the role of an exercise training program on the acute response of cytokines to exercise. 
One of the most important mechanisms that may play a decisive role in exercise effect on cytokines is weight loss during exercise program (Gleeson et al., 
2011). This has not been taken into consideration in most studies of exercise training in MS. It has been reported in Mokhtarzade et al., 2017 that weight loss following 
exercise is associated with an increase in the level of anti-inflammatory cytokines such as IL-10 and Adiponectin in pwMS. Therefore, in future studies, special attention 
should be paid to the concept of weight loss and its role in the effect of exercise on cytokines and adipokines in MS. 
Future research needs to incorporate as many of these quality measures to ensure accurate and reliable results are obtained with respect to MS disease. 
Moreover, other methodological weakness across the reviewed studies include the absence of healthy controls, engaged in similar training programs to compare directly 
the pattern of adaptability of healthy people with those individuals with MS. Although, studies that have been conducted on healthy subjects or even other diseases, 
suggest a positive and modulating effect on exercise training on cytokines and adipokines. Finally, there is an obvious gap in our understanding of the additive or 
synergistic role of pharmaceutical therapies and exercise that are important for guiding future research. 
 
4.4. Limitations 
One of the limitations of this study is that the results may not be generalizable to all MS patients; because the majority of studies recruited small samples of MS 
patients. On the other hand, most studies have not explained how to determine their sample sizes. Therefore, studies may suffer from type II statistical errors (incorrect 
rejection of a true null hypothesis). In addition, some studies (Golzari et al., 2010; Mokhtarzade et al., 2017) have only used females as samples, while the male to 
female ratio is 2 to 1 in MS, making generalizing the results difficult to all MS patients. However, Mokhtarzade et al., 2017 finds that males and females have different 
adipokines adaptation to the training period, and a different adipokine background between male and female subjects can result in an experimental bias (Mokhtarzade et 
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al., 2017). Other limitations of reviewed studies is the heterogeneity of the MS population study; some studies focused on RRMS patients but some studies focused or 
used other type of MS which maybe have major differences in the pattern of response of adipokines and cytokines. 
Based on the investigation effect of exercise training on a wide range of cytokines and adipokines, lack of consistent reporting and heterogeneity of 
experimental design and varied type of exercise programs used in the reviewed studies, performing a meta-analysis was not possible. Moreover, in two studies the 
dropout exceeded 15% and the main outcome measure was obtained from less than 85% of the sample (Deckx et al., 2016; Kierkegaard et al., 2016) this may result in 
insufficient power to detect statistically significant changes. 
Cytokines can be monitored using a variety of tools, methods and in different sites. Most studies have focused on assessing cytokines in serum, while assaying 
cytokines in the serum have several problems and can be inaccurate. Therefore, methods used to measure cytokines can be consider as a major limitations of the existing 
studies which can lead to the heterogeneity of results. 
A further limitation is related to database that were used in the current review study. Only articles published in 4 databases (PubMed, Cochrane Library, 
EMBASE, and PEDro), and English peer-reviewed journals, were included in the current study. Therefore, this review may have not been comprehensive enough to 
include all studies on the effects of exercise training on cytokines and adipokines profiles in MS patients. Despite this, databases used in the current review study are 
major electronic databases that index a great number of studies. In addition, the class of reviewed studies is limited, for example, cross over-design or cohort studies are 
necessary, and could make the conclusions of this study stronger. 
The majority of studies have neglected important notes in their methodology. For instance, nutritional considerations, menstrual cycle in females and the 
accurate assessment of the body composition were not considered completely. All these factors could influence outcomes, and could help in the interpretation of the 
effects of exercise training. In other hand, weight loss and body composition changes are one of the most important factors affecting adipokines and cytokines, while 
most studies have not been monitored body composition and weight loss response to exercise training. Finally, a short-term exercise period of some reviewed studies 
(three to eight weeks) is another important cause for null effect of exercise training. 
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4.5. Conclusion 
Overall, the limited and contradictory results that are summarized in the current study suggest that more extensive research is needed to better understand and quantify 
the role of regular physical activity on cytokines and adipokines in MS, while resolving the methodological weaknesses outlined in this study. The lack of systematic 
changes in cytokines and adipokines indicates that an anti-inflammatory effect of exercise is not the main underling mechanism that mediates positive effects of exercise 
on outcomes such as EDSS, fatigue and other clinical outcomes following a short-term training period (less than 6 months) in persons with MS. Importantly, no studies 
reported any harmful effects of exercise in relation to cytokines or adipokines and regular physical activity did not lead to inflammation or an increase in adipokines or in 
disease severity. Therefore, these findings indicate that an active lifestyle can be considered as an important part of MS treatment. Finally, evidence does not support the 
notion that the potential disease modifying effect of exercise in MS should be driven by underlying changes in cytokines 
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Figure 1 Flowchart of search results and study selection. Inclusion criteria was: English language, enrollment of MS patients, access to full text, studying regular 
physical activity, studying cytokines. 
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Table 1 The methodological quality of the reviewed studies using the PEDro scale and ANN classification. 
 Scales ANN 
classification 
First author Year #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 #11 Total  
Mokhtarzade 2017 1 1 1 1 0 0 0 1 1 1 1 7/10 I 
Briken 2016 1 1 1 1 0 0 0 1 1 1 1 7/10 I 
Alvarenga-Filho 2016 1 0 0 1 0 0 0 1 1 1 1 5/10 II 
Deckx 2016 1 1 1 1 0 0 1 0 1 1 1 7/10 II 
Kierkegaard 2016 1 0 0 1 0 0 0 0 1 0 1 3/10 IV 
Kjølhede 2015 1 1 1 1 0 0 1 1 1 1 1 8/10 I 
Ebrahimi 2015 1 1 0 1 0 0 0 1 1 1 1 6/10 II 
Bansi 2012 1 1 0 1 0 0 0 1 1 1 1 6/10 II 
Golzari 2010 1 1 0 1 0 0 0 1 1 1 1 6/10 II 
Castellano 2008 1 1 0 1 0 0 0 1 1 1 1 6/10 II 
White 2006 1 0 0 0 0 0 0 1 1 0 1 3/10 IV 
Schulz 2004 1 1 0 1 0 0 1 1 1 1 1 7/10 II 
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#1: Eligibility criteria (not included in the total score); #2: Random allocation; #3: Allocation was concealed; #4: The groups were similar on important criteria at the 
baseline; #5: Blind all subjects; #6: Blind therapy administration; #7: Blind all assessors; #8: Outcomes were obtained from more than 85%; #9: Intention to treat 
analysis; #10: Statistical comparisons between groups at least for one key factor; #11: Point estimates and variability. 
 
Table 2 Characteristics and protocol of the reviewed studies 
First author 
Year 
MS type Subjects  Age (years) EDSS Exercise Type Duration and Intensity 
Mokhtarzade 
2017 
RRMS Training group: 22 
Control group: 18 
32.0 ± 2.8 
31.3 ± 3.3 
1.8 ± 0.4 
1.6 ± 0.6 
Aerobic training: 
Upper and lower limb cycling 
8-week, 3 sessions per 
week, 60-75% Wmax 
Briken 
2016 
PPMS & 
SPMS 
Training group: 28 
Control group: 9 
49.9 ± 7.6 
50.4 ± 7.6 
4.9 ± 0.9 
4.9 ± 0.8 
Endurance training: 
arm ergometry, rowing and bicycle 
ergometry 
9-week, 2-3 sessions per 
week 
Alvarenga-Filho 
2016 
RRMS MS trained: 8 
MS untrained: 10 
Healthy control: 10 
41.1 ± 12.9 
35.2 ± 7.6 
39.7 ± 10.4 
0-2 
0-2.5 
Combined training: 
Cycling and Pilates exercises 
12-week, 3 sessions per 
week 
Deckx 
2016 
RRMS & 
CPMS 
Training group: 29 
Control group: 16 
47 ±2# 
50± 3# 
3 ± 0.2# 
3 ± 0.4# 
Combined training: 
Cycling, walking, running and 
resistance training 
12-week, 5 sessions per 2 
weeks 
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Kierkegaard 
2016
* 
RRMS Training group: 20 36.3±7.6 1-2.4 Whole body resistance training 
 
12-week, 2 sessions per 
week, 80% 1RM 
Kjølhede 
2015 
RRMS Training group: 16 
Control group: 16 
44.6±7 
42.2±8 
2.9 ± 1 
2.9 ± 1 
Upper and lower resistance training 24-week, 2 sessions per 
week 
Ebrahimi 
2015 
RRMS Training group: 16 
Control group: 14 
37.1±8.4 
40.8±10.6 
3.1 ± 1.2 
3.1 ± 0.8 
Whole body vibration 10 week, 3 sessions per 
week 
Bansi 
2012 
NR Land group: 28 
Water group: 24 
46.7–56.3 
44.6–55.1 
4.1–5.3 
4.0–5.2 
Endurance training: 
Ergometer land and water group 
3-week, 70% HRpeak 
Golzari 
2010 
NR Training group: 10 
Control group: 10 
32.2±7.6 
33.8±8.2 
2.1±1.1 
2.0 ±1.1 
Combined training: 
Endurance and resistance training 
8-week, 3 sessions per 
week 
Castellano 
2008 
RRMS MS trained: 11 
Healthy trained: 11 
40±10 
40±10 
 
0-5.5 Aerobic cycling training 
 
8-week, 3 sessions per 
week, 60% Vo2peak 
White 
2006* 
RRMS Training group: 10 47±12 3.8±0.9 Lower limb resistance training 8-week, 2 sessions per 
week, 50-70% MVC 
Schulz 
2004 
NR Training group: 15 
Control group: 13 
39±9 
40±11 
2.0±1.4 
2.5±0.8 
Aerobic cycling training 8-week, 2 sessions per 
week, 75% Wmax 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
28 
 
 
* Kierkegaard et al 2016 and White et al 2006 only used one group in their study, 
# 
Data Shown SD±SEM, NR: not reported; MS: multiple sclerosis; RRMS: relapsing-
remitting MS; PPMS: primary progressive MS; SPMS: secondary progressive MS; CPMS: Chronic Progressive MS; EDSS: Expanded Disability Status Scale; Wmax: 
watts maximum; 1RM: one repetition maximum; HRpeak: peak heart rate; Vo2peak: peak oxygen consumption; MVC: maximum voluntary contraction. 
 
 
 
Table 3 The overall results of the reviewed studies 
First author 
Year 
Main factors Sampling 
time 
Sample  
Main results 
RE AE S P C 
Mokhtarzade 
2017 
IL-10, TNF-α, 
Leptin, 
Adiponecrin 
×  ×   Responses to 8 weeks exercise training (cytokines): TNF-α ↓; IL-10 and IL-10/TNF-α ratio 
underwent no considerably change. 
Responses to 8 weeks exercise training (Adipokines): leptin ↓, Adiponectin ↑, Leptin/Adiponectin ↓. 
Clinical outcome: Fatigue ↓, QoL ↑. 
Briken 
2016 
Irsin, BDNF, 
IL-6 
× × ×   Responses to acute exercise: BDNF ↑ (immediately after exercise); Irisin and IL-6 underwent no 
considerably change. 
Responses to 9 weeks exercise training: Irsin, BDNF and IL-6 underwent no considerably change. 
Clinical outcome: Not reported. 
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Alvarenga-
Filho 
2016 
IL-6, IL-10, IL-
21, IL-22, TNF-
α, IFN-γ 
×     Responses to 12 weeks exercise training: IL-22 ↓; Other cytokines underwent no considerably 
change. # 
Clinical outcome: Fatigue ↓. 
Deckx 
2016 
IL-6, IL-10, IL-
12, TNF-α, 
TGF-β 
×   ×  Responses to 12 weeks exercise training: All measured cytokines underwent no considerably change. 
TNF-𝛼 secretion ↓ (upon LPS and IFN-𝛾 stimulation). 
Clinical outcome: Not reported. 
Kierkegaard 
2016
 
IL-1ra, IL-4, IL-
5, IL-6, IL-7, 
IL-8, IL-12, IL-
13, IL-17 
×   × × Responses to 12 weeks exercise training: Serum level of all measured cytokines ↓; CSF level of all 
measured cytokine underwent no considerably change. 
Clinical outcome: Anxiety ↓, Depression ↓, Fatigue ↓. 
Kjølhede 
2015 
IL-1β, IL-4, IL-
10, IL-17, IL-
23, TNF-α, IFN-
γ 
× ×  ×  Responses to acute exercise: All measured cytokine underwent no considerably change in the 
beginning (untrained state) and after of 24 weeks of exercise training (trained state). 
Responses to 12 weeks exercise training: All measured cytokines underwent no considerably change. 
Clinical outcome: Walking ability ↑. 
Ebrahimi 
2015 
Leptin, Gerlin, 
Testosterone 
×  ×   Responses to 10 weeks exercise training: Leptin, ghrelin and testosterone levels, ghrelin/leptin and 
testosterone/leptin ratio underwent no considerably change. 
Clinical outcome: EDSS ↓, Walking ability ↑, Balance ↑. 
Bansi IL-6, TNF-α, × ×  ×  Responses to acute exercise: BDNF ↑; IL-6, TNF-α, sIL-6R and NGF underwent no considerably 
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2012 sIL-6R, BDNF, 
NGF 
change. 
Responses to 3 weeks exercise training: BDNF ↑ (water group); IL-6, TNF-α, sIL-6R and NGF 
underwent no considerably change. 
Clinical outcome: Fatigue showed no considerably change. 
Golzari 
2010 
IL-4, IL-17,  
IFN-γ 
×   ×  Responses to 8 weeks exercise training: IL-17 ↓, IFN-γ ↓; IL-4 underwent no considerably change.* 
Clinical outcome: EDSS ↓, Balance ↑. 
Castellano 
2008 
IL-6, TNF-α, 
IFN-γ 
× ×  ×  Responses to acute exercise: 30 min postexercise IL-6 ↑, TNF-α ↓, IFN-γ ↓. 
Responses to 8 weeks exercise training: TNF-α ↑, IFN-γ ↑; IL-6 underwent no considerably change. 
Clinical outcome: EDSS ↓. 
White 
2006 
IL-2, IL-4, IL-6, 
IL-10, IFN-γ, 
TNF-α, CRP 
×  ×   Responses to 8 weeks exercise training:  IL-4 ↓, IL-10 ↓, CRP ↓, IFN-γ ↓, IL-2 ↓; IL-6 and TNF-α 
underwent no considerably change. 
Clinical outcome: Fatigue ↓. 
Schulz 
2004 
IL-6, sIL-6R, 
BDNF, NGF 
×   ×  Responses to 8 weeks exercise training:  IL-6, sIL-6R, BDNF and NGF underwent no considerably 
change. 
Clinical outcome: QoL ↑, Balance ↑. 
MS: multiple sclerosis; IL: Interleukin; IL-1ra: interleukin-1 receptor antagonist; sIL-6R: Soluble IL-6 receptor; IFN-γ: Interferon gamma; CRP: C-reactive protein; 
BDNF: Brain-derived neurotrophic factor; NGF: Nerve growth factor; TGF-β: Transforming growth factor beta. LPS: Lipopolysaccharides, EDSS: Expanded disability 
status scale, QoL: Quality of life, RE: rest, AE: after an exercise bout, S: serum, P: plasma or supernatant, C: Cerebrospinal fluid, ↑: significant increase, ↓: significant 
decrease. 
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# These results are based on cytokines that are produced by T cells. 
* These results were measured in both plasma concentrations and production by peripheral blood mononuclear cell (PBMC) status.  
 
 
 
 
 
 
 
 
